Global Vaccine Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Vaccine Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Market Overview:

The latest research study on the global Vaccine market finds that the global Vaccine market reached a value of USD 34262.07 million in 2022. It’s expected that the market will achieve USD 60183.12 million by 2028, exhibiting a CAGR of 9.84% during the forecast period.

Key Companies in the global Vaccine market covered in Chapter 3:

AstraZeneca plc
Sinovac Biotech Ltd.
Merck & Company Inc.
Madison Vaccines Incorporated
GlaxoSmithKline plc
Valneva SE
Daiichi Sankyo Company, Limited
Emergent BioSolutions Inc.
VBI Vaccine Inc.
Johnson & Johnson
Sanofi S.A.
Bavarian Nordic
BiondVax Pharmaceuticals Ltd.
CSL Limited
Abbott Laboratories
Inovio Pharmaceuticals Inc.
Pfizer, Inc.

In Chapter 4 and Chapter 14.2, on the basis of types, the Vaccine market from 2018 to 2029 is primarily split into:

Live-attenuated Vaccines
Inactivated Vaccines
Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines
Toxoid Vaccines
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Vaccine market from 2018 to 2029 covers:

Hospitals
Clinics
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)